Cover Image

The global aHUS registry: methodology and initial patient characteristics

Show other versions (1)

Atypical hemolytic uremic syndrome (aHUS) is a rare, genetically-mediated systemic disease most often caused by chronic, uncontrolled complement activation that leads to systemic thrombotic microangiopathy (TMA) and renal and other end-organ damage.

Saved in:
Bibliographic Details
Main Authors: Licht, Christoph (Author) , Ardissino, Gianluigi (Author) , Ariceta, Gema (Author) , Cohen, David (Author) , Cole, J. Alexander (Author) , Gasteyger, Christoph (Author) , Greenbaum, Larry A. (Author) , Johnson, Sally (Author) , Ogawa, Masayo (Author) , Schaefer, Franz (Author) , Vande Walle, Johan (Author) , Frémeaux-Bacchi, Véronique (Author)
Format: Article (Journal)
Language:English
Published: 10 December 2015
In: BMC nephrology
Year: 2015, Volume: 16, Pages: 1-8
ISSN:1471-2369
DOI:10.1186/s12882-015-0195-1
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12882-015-0195-1
Verlag, lizenzpflichtig, Volltext: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-015-0195-1
Get full text
Author Notes:Christoph Licht, Gianluigi Ardissino, Gema Ariceta, David Cohen, J. Alexander Cole, Christoph Gasteyger, Larry A. Greenbaum, Sally Johnson, Masayo Ogawa, Franz Schaefer, Johan Vande Walle and Véronique Frémeaux-Bacchi
Description
Summary:Atypical hemolytic uremic syndrome (aHUS) is a rare, genetically-mediated systemic disease most often caused by chronic, uncontrolled complement activation that leads to systemic thrombotic microangiopathy (TMA) and renal and other end-organ damage.
Item Description:Gesehen am 22.06.2020
Physical Description:Online Resource
ISSN:1471-2369
DOI:10.1186/s12882-015-0195-1

Similar Items